Nuvalent announced that it has commenced an underwritten public offering of $300M of its shares of Class A common stock. J.P. Morgan, TD Cowen, Piper Sandler and BMO Capital Markets are acting as joint book-running managers for the offering. Wedbush Securities is acting as a manager.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NUVL:
- Nuvalent price target raised to $100 from $65 at Stifel
- Nuvalent announces updated preliminary data from ALKOVE-1 trial
- JPMorgan biotech analysts hold an analyst/industry conference call
- Nuvalent price target raised to $73 from $52 at BMO Capital
- Nuvalent price target raised to $65 from $53 at Wedbush
